# To Compare the Pharmacokinetics and Safety After a Single Dose Administration of IN-G00002 and IN-R00002 in Healthy Adult Volunteers

> **NCT06725355** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **HK inno.N Corporation** · enrollment: 60 (estimated)

## Conditions studied

- Non-valvular Atrial Fibrillation (NVAF)

## Interventions

- **DRUG:** IN-R00002
- **DRUG:** IN-G00002

## Key facts

- **NCT ID:** NCT06725355
- **Lead sponsor:** HK inno.N Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-08-16
- **Primary completion:** 2024-10-08
- **Final completion:** 2025-01-14
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06725355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06725355, "To Compare the Pharmacokinetics and Safety After a Single Dose Administration of IN-G00002 and IN-R00002 in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06725355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*